How much funding has Par Pharmaceutical raised?

Par Pharmaceutical has raised $1.9B in total funding, most recently a Private Equity round.

Who are Par Pharmaceutical's investors?

Par Pharmaceutical's investors include Endo International, TPG (Growth/Rise).

When was Par Pharmaceutical founded?

Par Pharmaceutical was founded in 1978.

Where is Par Pharmaceutical headquartered?

Par Pharmaceutical is headquartered in Woodcliff Lake, New Jersey, United States.

What industry is Par Pharmaceutical in?

Par Pharmaceutical operates in Healthcare.

How many employees does Par Pharmaceutical have?

Par Pharmaceutical has 1001-5000 employees.

Par Pharmaceutical

Acquired

Elevating the Essentials™

Woodcliff Lake, United States · Founded 1978 · $1.9B raised

Healthcare

Headquarters: Woodcliff Lake, New Jersey
Employees: 1001–5000
Founded: 1978
Business Model: B2B
Website: parpharm.com

Total Funding: $1.9B
Last Round: $1.9B Private EquityJul 2012
Rounds: 1
Acquisition Date: May 2015

About

Par Pharmaceutical (now operating as Par Health following its 2015 acquisition by Endo International) is a specialty pharmaceutical company focusing on the development, licensing, manufacturing, and marketing of generic and branded pharmaceutical products. The company specializes in oral solid dosage forms and injectables, serving healthcare providers and pharmaceutical distributors across the United States.

Summary

Par Pharmaceutical is a Healthcare company based in Woodcliff Lake, United States, founded in 1978. It has raised $1.9B in total across 1 round, most recently a $1.9B Private Equity round in Jul 2012. Investors include Endo International and TPG (Growth/Rise).